Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-11

Clinical Trial Update: L-carnitine on the Prevention of Renal Scarring in Acute Pyelonephritis [Phase 3]

View source ↗

Summary

This document updates a Phase 3 clinical trial evaluating L-carnitine for the prevention of renal scarring in acute pyelonephritis. The study status is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-carnitine (L-carnitine)

Snippet

Sponsor: Shahid Beheshti University | Conditions: Acute Pyelonephritis(APN) | Phase 3 | Status: UNKNOWN